In ALS motor neurons, disease-modified RBM45 hijacks RNA processing condensates through altered LLPS behavior, displacing TDP-43 into pathological aggregates. Similarly, in Frontotemporal dementia (particularly FTD-TDP subtype), FUS (Fused in Sarcoma) - another low-complexity domain RNA-binding protein - undergoes post-translational modifications (phosphorylation, acetylation) that stabilize its condensates at nuclear speckles and stress granules. These dominant FUS condensates may displace TDP-43 and hnRNP A1, driving TDP-43 aggregation pathology characteristic of FTD-TDP.
Analogy rationale: Both RBM45 and FUS are neuronal RNA-binding proteins with low-complexity domains that undergo LLPS. FUS is already implicated in FTD (mutations cause familial FTD/ALS), exhibits phase separation behavior, and its aggregates are found in a subset of FTD cases. The mechanistic logic of LCD-mediated condensate dominance transfers directly.
No linked papers recorded for this hypothesis yet.
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for FUS.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.